Related Experiment Video
Updated: Jun 4, 2025

05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
11.2K
Computer Assisted Nodule Analysis and Risk Yield is Associated With Occult Lymph Node Status in Clinical Stage I-IIA
Duy Pham1, Ju Ae Park2, Hongkun Wang3
1University of Virginia School of Medicine, Charlottesville, VA.
Clinical Lung Cancer
|December 25, 2024
Summary
Computer Assisted Nodule Analysis and Risk Yield (CANARY) analysis helps identify occult lymph node metastases in early-stage lung adenocarcinoma. Poor risk profiles identified by CANARY significantly increase the likelihood of lymph node involvement.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Current staging methods for lung adenocarcinoma may not detect all occult lymph node (OLN) disease.
- Accurate assessment of OLN status is crucial for treatment planning in early-stage lung cancer.
Purpose of the Study:
- To evaluate the utility of Computer Assisted Nodule Analysis and Risk Yield (CANARY) analysis in distinguishing OLN status.
- To determine if CANARY risk profiles can predict the presence of OLN metastases in early-stage lung adenocarcinoma.
Main Methods:
- Retrospective review of 228 patients with surgically resected clinical stage I-IIA lung adenocarcinoma (2016-2021).
- Preoperative imaging analyzed by CANARY software, categorizing lesions into good, intermediate, and poor risk.
- Correlation of CANARY risk profiles with OLN status determined by pathology.
- Statistical analysis using Pearson's Chi-square and logistic regression models (α=0.05).
Main Results:
- 28 (12.3%) patients had OLN metastases.
- A significant association was found between CANARY risk profile and OLN metastases (χ2 = 9.9, P = .007).
- Patients with a poor CANARY risk profile had a >3-fold increased likelihood of OLN metastases (OR = 3.3, 95% CI: 1.6-9.2, P = .007) compared to good/intermediate risk groups.
Conclusions:
- CANARY analysis effectively risk-stratifies the likelihood of OLN metastases in early-stage lung adenocarcinoma.
- CANARY serves as a valuable non-invasive tool to aid in personalized treatment planning for lung cancer patients.

